<DOC>
	<DOCNO>NCT00395733</DOCNO>
	<brief_summary>The purpose study determine contrast agent effective safe Magnetic Resonance Imaging ( MRI ) vascular diseases patient Chinese origin .</brief_summary>
	<brief_title>Efficacy Safety Study Evaluate Gadavist ( Gadobutrol ) Contrast Agent Magnetic Resonance Imaging ( MRI ) Vascular Diseases Chinese Patients</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer HealthCare AG , Germany . Bayer HealthCare AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>Chinese origin Known suspect blood vessel diseases Pregnancy Lactation Conditions interfere MRI Allergy contrast agent drug Participation trial Require emergency treatment Severely impaired liver kidney function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Gadovist</keyword>
	<keyword>Gadavist</keyword>
	<keyword>MRI Imaging</keyword>
	<keyword>vascular disease</keyword>
	<keyword>Chinese</keyword>
</DOC>